ATE273022T1 - Verfahren zur verstärkung zellularer immunantworten - Google Patents

Verfahren zur verstärkung zellularer immunantworten

Info

Publication number
ATE273022T1
ATE273022T1 AT93921698T AT93921698T ATE273022T1 AT E273022 T1 ATE273022 T1 AT E273022T1 AT 93921698 T AT93921698 T AT 93921698T AT 93921698 T AT93921698 T AT 93921698T AT E273022 T1 ATE273022 T1 AT E273022T1
Authority
AT
Austria
Prior art keywords
immune responses
cellular immune
enhancing cellular
enhancing
immunogen
Prior art date
Application number
AT93921698T
Other languages
English (en)
Inventor
Balbir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE273022T1 publication Critical patent/ATE273022T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
AT93921698T 1992-09-28 1993-09-21 Verfahren zur verstärkung zellularer immunantworten ATE273022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28
PCT/US1993/008900 WO1994007531A1 (en) 1992-09-28 1993-09-21 Method of enhancing cell mediated immune responses

Publications (1)

Publication Number Publication Date
ATE273022T1 true ATE273022T1 (de) 2004-08-15

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921698T ATE273022T1 (de) 1992-09-28 1993-09-21 Verfahren zur verstärkung zellularer immunantworten

Country Status (11)

Country Link
EP (1) EP0839050B1 (de)
JP (1) JPH08502253A (de)
AT (1) ATE273022T1 (de)
AU (1) AU687750B2 (de)
CA (1) CA2145760A1 (de)
DE (1) DE69333588T2 (de)
DK (1) DK0839050T3 (de)
ES (1) ES2225825T3 (de)
MX (1) MX9306016A (de)
PT (1) PT839050E (de)
WO (1) WO1994007531A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060284B1 (en) 1999-08-03 2006-06-13 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
JP2005515162A (ja) * 2001-07-02 2005-05-26 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ(Mycoplasmahyopneumoniae)を用いた単回ワクチン接種
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
EP1912680B1 (de) 2005-06-15 2014-11-26 The Ohio State University Research Foundation Her-2-peptide
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
ES2559445T3 (es) 2010-05-11 2016-02-12 Intervet International B.V. Vacuna contra Mycoplasma hyopneumoniae apta para la administración en presencia de anticuerpos de origen materno

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
AU657907B2 (en) * 1990-05-29 1995-03-30 Wyeth Holdings Corporation Mycoplasma hyopneumoniae vaccine
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
CA2145760A1 (en) 1994-04-14
DE69333588D1 (de) 2004-09-16
WO1994007531A1 (en) 1994-04-14
JPH08502253A (ja) 1996-03-12
MX9306016A (es) 1995-01-31
ES2225825T3 (es) 2005-03-16
AU687750B2 (en) 1998-03-05
AU4931293A (en) 1994-04-26
DK0839050T3 (da) 2004-10-25
EP0839050A1 (de) 1998-05-06
EP0839050B1 (de) 2004-08-11
EP0839050A4 (de) 1998-05-06
DE69333588T2 (de) 2005-08-04
PT839050E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
ATE95425T1 (de) Impfstofformulierung.
IL96893A0 (en) Vaccines against cancer and infectious diseases
ATE127345T1 (de) Stressproteine und verwendungen dafür.
EE200100203A (et) Meetod immuunvastuse indutseerimiseks polüpeptiidse antigeeni vastu ja rakuga seotud polüpeptiidse antigeeni mahasurumiseks loomorganismil, selle meetodi kasutamine eesnäärme- ja rinnavähi raviks ning immunogeenne kompositsioon
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
DK0714444T3 (da) Dæmpning af en immundominant epitop i et antigen til anvendelse i plante-, dyre- og humanvacciner og immunbehandlinger
ATE203677T1 (de) Legionellosis-impfstoffe und verfahren zur deren herstellung
ES2090332T3 (es) Tejido linfoide humano en un hospedador inmunocomprometido.
DE69536091D1 (de) Immunisierung durch Impfung von DNS Transkriptionseinheit
DE3486292D1 (de) Tierärztliche Impfstoffe.
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
ES537459A0 (es) Procedimiento para preparar anticuerpos anti-idiotipicos
DE69333588D1 (de) Verfahren zur verstärkung zellularer immunantworten
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
ATE196425T1 (de) Impfstoff gegen die lyme-krankheit
DK16087A (da) Mastitis-vaccine
DE3467813D1 (en) Diagnostic antigen for swine pseudorabies disease virus carriers
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
Toma et al. Vaccination of dogs against rabies. Comparison of serological responses one year after intradermal or subcutaneous vaccination
ES255146A3 (es) Metodo de preparaciën de antigenos inmunizadores eficaces en la vacunaciën de ganado vacuno
NO905619L (no) Identifikasjon av humane t-lymfocyttepitoper i patogener for vaksineutvikling.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0839050

Country of ref document: EP